Lenvima plus Keytruda did not significantly improve survival or progression-free survival compared to chemotherapy in advanced endometrial cancer. The study involved 842 patients, with no new safety ...

Four PRs were reported among patients with endometrial cancer. The part Ib data built on results from the dose escalation ...

The goal is to treat various solid tumors, including gynecological cancers such as breast cancer, ovarian cancer, and endometrial cancer ... Following the Phase 1a dose escalation trial, a ...